Ectopic calcification: Importance of common nanoparticle scaffolds containing oxidized acidic lipids

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 2, 2014, Pages 441-450

  Kumon, Hiromi ^a   Matsuura, Eiji ^a   Nagaoka, Noriyuki ^a   Yamamoto, Toshio ^a   Uehara, Shinya ^a   Araki, Motoo ^a   Matsunami, Yukana ^a   Kobayashi, Kazuko ^a   Matsumoto, Akira ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Ectopic calcification; Nanobacteria like particles; Nanoparticles; Oxidized lipids

Indexed keywords

ECTOPIC CALCIFICATION; NANOBACTERIA-LIKE PARTICLES; NANOPARTICLES; OXIDIZED LIPIDS;

ANIMALS; ANTIBODIES, MONOCLONAL; AORTIC VALVE; CALCINOSIS; CULTURE MEDIA; IMMUNOGLOBULIN M; INFLAMMATION; LIPIDS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; NANOTECHNOLOGY; OSTEOCALCIN; OXYGEN; URINARY CALCULI;

EID: 84895070071     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.08.010     Document Type: Article

References (39)

1. Kajander E.O., Kuronen I., Akerman K., Pelttari A., Ciftcioglu N. Nanobacteria from blood, the smallest cultureable autonomously replicating agent on earth. Proc Soc Photo Opt Instrum Eng 1997, 111:420-428.
2. Kajander E.O. Nanobacteria-propagating calcifying nanoparticles. Lett Appl Microbiol 2006, 42:549-552.
3. Cisar J.O., Xu D.Q., Thompson J., Swaim W., Hu L., Kopecko D.J. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 2000, 97:11511-11515.
4. Raoult D., Drancourt M., Azza S., Nappex C., Guieu R., Rolain J.M., et al. Nanobacteria are mineralo-fetuin complexes. PLoS Pathog 2008, 4:e41.
5. Martel J., Young J.D. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA 2008, 105:5549-5551.
6. Young J.D., Martel J., Young L., Wu C.Y., Young A., Young D. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 2009, 4:e441.
7. Martel J., Wu C.Y., Young J.D. Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles. PLoS One 2010, 5:e0343.
8. Shoskes D.A., Thomas K.D., Gomez E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005, 173:474-477.
9. Altundag K., Altundag O., Akyurek S., Atik M.A. Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J 2006, 12:287.
10. Zhou Z., Hong L., Shen X., Rao X., Jin X., Lu G., et al. Detection of nanobacteria infection in type III prostatitis. Urology 2008, 71:1091.
11. Jones J.A., Ciftcioglu N., Schmid J.F., Barr Y.R., Griffith D. Calcifying nanoparticles (nanobacteria): an additional potential factor for urolithiasis in space flight crews. Urology 2009, 73:210e11-210e13.
12. Zhang Q.H., Lu G.S., Shen X.C., Zhou Z.S., Fang Q., Zhang X., et al. Nanobacteria may be linked to testicular microlithiasis in infertility. J Androl 2010, 31:121-125.
13. Hu Y.R., Zhao Y., Sun Y.W., Lu W.D., Li J.M., Wu Z.S., et al. Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol 2010, 19:286-292.
14. Shen X., Ming A., Li X., Zhou Z., Song B. Nanobacteria: a possible etiology for type III prostatitis. J Urol 2010, 184:364-369.
15. Tulunay K.C., Sinan E.F., Hasan T., Candemir B., Ozdol C., Arikan A.O., et al. Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification. Coron Artery Dis 2011, 22:394-400.
16. Candemir B., Ertas F.S., Kaya C.T., Ozdol C., Hasan T., Akan O.A., et al. Association between antibodies against calcifying nanoparticles and mitral annular calcification. J Heart Valve Dis 2010, 19:745-752.
17. Kutikhin A.G., Brusina E.B., Yuzhalin A.E. The role of calcifying nanoparticles in biology and medicine. Int J Nanomedicine 2012, 7:339-350.
18. Guo Y., Zhang D., Lu H., Luo S., Shen X. Association between calcifying nanoparticles and placental calcification. Int J Nanomedicine 2012, 7:1679-1686.
19. Kajander E.O., Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 1998, 95:8274-8279.
20. Ciftcioglu N., Bjorklund M., Kuorikoski K., Bergstrom K., Kajander E.O. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999, 56:1893-1898.
21. Kumon H., Matsumoto A., Uehara S., Abarzua F., Araki M., Tsutsui K., et al. Detection and isolation of nanobacteria-like particles from urinary stones: long-withheld data. Intl J Urol 2011, 18:458-465.
22. Kondo A., Inagaki J., Kobayashi K., Tsukamoto H., Yamamoto D., Nakatsuka M., et al. Characterization of a murine anti-laminin-1 monoclonal antibody (AK8) produced by immunization with mouse-derived laminin-1. Clin Dev Immunol 2005, 12:67-73.
23. Kobayashi K., Matsuura E., Liu Q., Furukawa J., Kaihara K., Inagaki J., et al. A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low-density lipoprotein by macrophages. J Lipid Res 2001, 42:697-709.
24. Ciftcioglu N., Miller-Hjelle M.A., Hjelle J.T., Kajander E.O. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002, 46:2077-2086.
25. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
26. Tateno S., Sinmyo R., Hirose K., Nishioka H. The advanced ion-milling method for preparation of thin film using ion slicer: application to a sample recovered from diamond-anvil cell. Rev Sci Instrum 2009, 80:013901.
27. Meir K.S., Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
28. Aikawa E., Nahrendorf M., Sosnovik D., Lok V.M., Jaffer F.A., Aikawa M., et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
29. Bjorklund M., Ciftcioglu N., Kajander E.O. Extraordinary survival of nanobacteria under extreme conditions. Proc Soc Photo Opt Instrum Eng 1998, 3441:23.
30. Grieb T., Forng R.Y., Brown R., Owolabi T., Maddox E., McBain A., et al. Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations. Biologicals 2002, 30:207-216.
31. Lacroix M., Ouattara B. Combined industrial processes with irradiation to assure innocuity and preservation of food products-a review. Food Res Int 2000, 33:719-724.
32. Nakazawa T., Terayama K., Okuaki H., Yukawa O. Localization of lipid peroxidation products in liposomes after gamma-irradiation. Biochim Biophys Acta 1984, 769:323-329.
33. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994, 179:457-462.
34. Seddon J.M., Templer R.H. Polymorphism of lipid-water systems. Handbook of Biological Physics 1995, Vol. 1, Chapter 3:97-160. Elsevier Science B.V., Amsterdam (The Netherlands). R. Lipowsky, E. Sackmann (Eds.).
35. Takadama H., Kim H.M., Kokubo T., Nakamura T. TEM-EDX study of mechanism of bonelike apatite formation on bioactive titanium metal in simulated body fluid. J Biomed Mater Res 2001, 57:441-448.
36. Kim H.M., Himeno T., Kawashita M., Kokubo T., Nakamura T. The mechanism of biomineralization of bone-like apatite on synthetic hydroxyapatite: an in vitro assessment. J R Soc Interface 2004, 22:17-22.
37. Sasaki T., Goldberg M., Takuma S., et al. Forming and maturing enamel structure. Cell biology of tooth enamel formation. Functional electron microscopic monographs (chapter 3) 1990, 138. Karger Publishers, Basel (Switzerland). H. Myers (Ed.).
38. Nylen M.U., Eanes E.D., Omnell K.A. Crystal growth in rat enamel. J Cell Biol 1963, 18:109-123.
39. Matsuura E., Kobayashi K., Tabuchi M., Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006, 45:466-486.